These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18805465)

  • 1. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.
    Hickey MA; Kosmalska A; Enayati J; Cohen R; Zeitlin S; Levine MS; Chesselet MF
    Neuroscience; 2008 Nov; 157(1):280-95. PubMed ID: 18805465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
    Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
    Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease.
    Abada YS; Schreiber R; Ellenbroek B
    Behav Brain Res; 2013 Feb; 238():243-51. PubMed ID: 23123142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.
    Rising AC; Xu J; Carlson A; Napoli VV; Denovan-Wright EM; Mandel RJ
    Exp Neurol; 2011 Apr; 228(2):173-82. PubMed ID: 21192926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
    Menalled LB; Kudwa AE; Miller S; Fitzpatrick J; Watson-Johnson J; Keating N; Ruiz M; Mushlin R; Alosio W; McConnell K; Connor D; Murphy C; Oakeshott S; Kwan M; Beltran J; Ghavami A; Brunner D; Park LC; Ramboz S; Howland D
    PLoS One; 2012; 7(12):e49838. PubMed ID: 23284626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.
    Smith GA; Rocha EM; McLean JR; Hayes MA; Izen SC; Isacson O; Hallett PJ
    Hum Mol Genet; 2014 Sep; 23(17):4510-27. PubMed ID: 24728190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of delayed aging on phenotype and striatal pathology in a murine model of Huntington disease.
    Tallaksen-Greene SJ; Sadagurski M; Zeng L; Mauch R; Perkins M; Banduseela VC; Lieberman AP; Miller RA; Paulson HL; Albin RL
    J Neurosci; 2014 Nov; 34(47):15658-68. PubMed ID: 25411494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.
    Franich NR; Hickey MA; Zhu C; Osborne GF; Ali N; Chu T; Bove NH; Lemesre V; Lerner RP; Zeitlin SO; Howland D; Neueder A; Landles C; Bates GP; Chesselet MF
    J Neurosci Res; 2019 Dec; 97(12):1590-1605. PubMed ID: 31282030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice.
    Menalled LB; Sison JD; Wu Y; Olivieri M; Li XJ; Li H; Zeitlin S; Chesselet MF
    J Neurosci; 2002 Sep; 22(18):8266-76. PubMed ID: 12223581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
    Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
    J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington's Disease.
    Peng Q; Wu B; Jiang M; Jin J; Hou Z; Zheng J; Zhang J; Duan W
    PLoS One; 2016; 11(2):e0148839. PubMed ID: 26859386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.
    Hickey MA; Zhu C; Medvedeva V; Lerner RP; Patassini S; Franich NR; Maiti P; Frautschy SA; Zeitlin S; Levine MS; Chesselet MF
    Mol Neurodegener; 2012 Apr; 7():12. PubMed ID: 22475209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
    Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
    Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knock-in mouse models of Huntington's disease.
    Menalled LB
    NeuroRx; 2005 Jul; 2(3):465-70. PubMed ID: 16389309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
    Heikkinen T; Lehtimäki K; Vartiainen N; Puoliväli J; Hendricks SJ; Glaser JR; Bradaia A; Wadel K; Touller C; Kontkanen O; Yrjänheikki JM; Buisson B; Howland D; Beaumont V; Munoz-Sanjuan I; Park LC
    PLoS One; 2012; 7(12):e50717. PubMed ID: 23284644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease.
    Zarringhalam K; Ka M; Kook YH; Terranova JI; Suh Y; King OD; Um M
    Behav Brain Res; 2012 Apr; 229(1):216-25. PubMed ID: 22266926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington's disease knock-in mice.
    Brooks S; Higgs G; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):182-8. PubMed ID: 20457230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.
    Yhnell E; Dunnett SB; Brooks SP
    J Huntingtons Dis; 2016 May; 5(2):149-61. PubMed ID: 27258586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
    Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
    Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing.
    Hickey MA; Gallant K; Gross GG; Levine MS; Chesselet MF
    Neurobiol Dis; 2005 Oct; 20(1):1-11. PubMed ID: 16137562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.